Our Portfolio

Active Investments & Innovative Technologies

Shaping The Future

Luzmon Medical believes in more than just investing in projects—we work hands on in transforming ideas that align with our vision. By collaborating closely with our partners, we develop innovations that address pressing healthcare challenges and pave the way for groundbreaking advancements. Luzmon Medical prioritizes initiatives that improve patient outcomes, enhance accessibility to advanced treatments, and create sustainable solutions for the healthcare community. We focus on empowering change through active engagement with every venture.

Developing Together

Our approach is rooted in partnership. Luzmon Medical works side by side with our collaborators, fostering shared growth and innovation. We’re not just investing; we’re contributing hands-on and operationally to the management teams and board of directors of our portfolio partners to build a future where health technologies meet the highest standards of care.

By aligning active investment with a passion for advancing healthcare, Luzmon Medical is shaping a future where innovation meets purpose. Join us in transforming ideas into impactful realities.

Vilje Bionics is transforming lives with VilPower, the world’s first assistive device designed to restore full arm functionality. This innovative motorized orthosis supports natural movement of the shoulder, elbow, wrist, and grip, giving independence and freedom back to those with impaired arm function, such as stroke survivors. Easy to use in everyday life and customizable to individual needs, VilPower empowers users to perform daily tasks and train their arms to improve mobility. Luzmon Medical and Vilje Bionics, are committed to creating a world where everyone, regardless of arm impairment, has equal opportunities to live independently and thrive.

CMedical is a leading provider of women’s reproductive healthcare, combining professional precision with compassionate care. Their clinics specialize in diagnosing and treating conditions of the internal and external genitalia, pelvic floor disorders, and infertility. As a private healthcare provider, they offer personalized solutions, whether self-funded or covered by health insurance. With clinics across Sweden and Norway, Luzmon Medical partnered with them and their interdisciplinary teams of expert surgeons, gynecologists, and fertility specialists to ensure that every woman receives comprehensive support in one place. Luzmon Medical and CMedical believe in creating life, empowering women, and prioritizing their health at every step.

Matrix Muscle Support (MMS) is a Med-Tech company founded in 2021, focused on addressing the growing challenges of physical inactivity. They offer two key solutions: licensing of enabling techniques for optimized human electrical stimulation and The Matrix-System for preventing worldwide health issues. With over 20 years of research at Karolinska Institutet and Karolinska University Hospital in Stockholm, Sweden, they developed innovative technologies to combat immobility and improve lower limb blood flow, reducing the risk of blood clots and promoting overall health. Luzmon Medical works with their team to create advanced, tailored solutions that enhance mobility and support better health for individuals globally.

Sulforaplus by Optisan is a natural food supplement developed and produced in Norway to preserve the nutrients and active ingredients found in broccoli sprouts. Approved for clinical studies, it is used to test the effects of sulforaphane, a powerful compound with numerous health benefits. Each daily dose contains the equivalent of 100 grams of fresh broccoli sprouts, delivering a natural source of sulforaphane derived from whole sprouts, not extracts. Their unique production method ensures the bioactive process of the broccoli sprouts is preserved, resulting in a more stable and higher amount of sulforaphane compared to similar products. SulforaPlus guarantees the potency and effectiveness of this important active ingredient for optimal health.